Integra Lifesciences Holdings Corp (IART)
23.27
-0.04
(-0.17%)
USD |
NASDAQ |
Nov 14, 16:00
23.27
0.00 (0.00%)
After-Hours: 20:00
Integra Lifesciences Holdings Research and Development Expense (Quarterly): 27.44M for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 27.44M |
| June 30, 2024 | 29.77M |
| March 31, 2024 | 26.96M |
| December 31, 2023 | 24.28M |
| September 30, 2023 | 26.60M |
| June 30, 2023 | 26.59M |
| March 31, 2023 | 26.72M |
| December 31, 2022 | 26.78M |
| September 30, 2022 | 24.74M |
| June 30, 2022 | 25.59M |
| March 31, 2022 | 24.08M |
| December 31, 2021 | 24.72M |
| September 30, 2021 | 25.83M |
| June 30, 2021 | 20.12M |
| March 31, 2021 | 22.37M |
| December 31, 2020 | 22.18M |
| September 30, 2020 | 19.46M |
| June 30, 2020 | 14.93M |
| March 31, 2020 | 20.82M |
| December 31, 2019 | 24.62M |
| September 30, 2019 | 19.00M |
| June 30, 2019 | 17.63M |
| March 31, 2019 | 18.32M |
| December 31, 2018 | 20.30M |
| September 30, 2018 | 20.31M |
| Date | Value |
|---|---|
| June 30, 2018 | 19.11M |
| March 31, 2018 | 18.32M |
| December 31, 2017 | 17.18M |
| September 30, 2017 | 15.03M |
| June 30, 2017 | 15.75M |
| March 31, 2017 | 15.49M |
| December 31, 2016 | 13.90M |
| September 30, 2016 | 15.12M |
| June 30, 2016 | 14.68M |
| March 31, 2016 | 14.45M |
| December 31, 2015 | 13.87M |
| September 30, 2015 | 13.94M |
| June 30, 2015 | 12.01M |
| March 31, 2015 | 11.08M |
| December 31, 2014 | 10.01M |
| September 30, 2014 | 11.13M |
| June 30, 2014 | 13.74M |
| March 31, 2014 | 12.57M |
| December 31, 2013 | 5.045M |
| September 30, 2013 | 13.05M |
| June 30, 2013 | 11.81M |
| March 31, 2013 | 12.72M |
| December 31, 2012 | 12.86M |
| September 30, 2012 | 13.10M |
| June 30, 2012 | 13.13M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
14.93M
Minimum
Jun 2020
29.77M
Maximum
Jun 2024
24.23M
Average
24.73M
Median
Research and Development Expense (Quarterly) Benchmarks
| Boston Scientific Corp | 407.00M |
| ResMed Inc | 79.52M |
| Perspective Therapeutics Inc | 9.275M |
| Xtant Medical Holdings Inc | 0.636M |
| Catheter Precision Inc | 0.081M |